Novo Nordisk (NVO) Financial Analysis & Valuation | Quarter Chart

Novo Nordisk (NVO)

NVO
Price: $40.46
Fair Value: 🔒
🔒score
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obe... more
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufactu... more
Description Shares
Market Cap$179.81BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryDKCEOMaziar Mike Doustdar
IPO Date1981-04-30CAGR0.11%
Employees77,406Websitewww.novonordisk.com
Div. Yield544.01%Payout Ratio0.51%
Buy Back Yield88.16%Total Yield632.17%
NVO chart loading...
Fundamentals Technicals
Enterprise Value$1529.77BP/E Ratio11.15
Forward P/E1.88PEG Ratio-2.42
P/S Ratio0.04P/B Ratio0.06
P/CF Ratio0.08P/FCF Ratio0.17
EPS$3.63EPS Growth 1Y1.81%
EPS Growth 3Y88.31%EPS Growth 5Y155.6%
Revenue Growth 1Y2.34%Gross Margin0.81%
Operating Margin0.41%Profit Margin0.33%
ROE0.61%ROA0.19%
ROCE0.39%Current Ratio0.8
Quick Ratio0.57Cash Ratio0.12
Debt/Equity0.67Interest Coverage18.86
Altman Z Score4.1Piotroski Score6

View Novo Nordisk financial charts →